Mitchell Shawnte
SEC CIK 1749432 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | CLO | 233 | — | $951.5K | 2 | 2026-03-03 | 2026-03-03 |
Most active insiders at OLMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CLARK IAN T | Dir | — | $7.87M |
| 2 | Zojwalla Naseem | Chief Medical Off | — | $7.53M |
| 3 | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | — | $4.66M |
| 4 | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | — | $2.98M |
| 5 | Mitchell Shawnte | CLO | — | $951.5K |
| 6 | Harmon Cyrus | Dir | — | $743.8K |
| 7 | Austin Sasha Lu | VP of Fin, Ctrl | — | — |
| 8 | Bohen Sean | Pres, CEO, Dir | — | — |
| 9 | RAPPAPORT ANDREW | Dir | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-03+ | OLMA | Olema Pharmaceuticals, Inc. | Mitchell Shawnte | CLO | S - Sale+OE | $23.79 | -40.0K | 233 | -99% | -$951.5K |
| DM | 2026-03-05 | 2026-03-03+ | OLMA | Olema Pharmaceuticals, Inc. | Mitchell Shawnte | CLO | M - OptEx | $4.37 | +40.0K | 15.0K | New | +$174.8K |
Purchase Sale Sale after option exercise All abbreviations